VERICI DX PLC

• ◆

  Material uncertainty over going concern

  The directors believe that additional funding can be obtained to enable the Parent Company and the Group to continue in existence for a period of at least 12 months. However, there is no guarantee that sufficient cash inflows from the Fundraising or other sources will be forthcoming, representing a material uncertainty in relation to funding which may result in the Group not being a going concern.

• ·

  Going-concern uncertainty disclosed

Figures converted to GBP from USD at 0.743 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.

1. VERICI DX PLC 2020-09-09 → present
2. VERICI DX LIMITED 2020-04-22 → 2020-09-09

Accounting basis

IFRS

Reporting scope

Consolidated group

Auditor

Crowe U.K. LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“The directors believe that additional funding can be obtained to enable the Parent Company and the Group to continue in existence for a period of at least 12 months. However, there is no guarantee that sufficient cash inflows from the Fundraising or other sources will be forthcoming, representing a material uncertainty in relation to funding which may result in the Group not being a going concern.”

Group structure

1. VERICI DX PLC · parent
   1. Verici Dx Inc 100% · United States of America · Development of prognostic and diagnostic tests for kidney transplant patients

Significant events

• “Earlier this month (post-period end) we concluded an equity fundraise which generated gross proceeds of £2.6m.”
• “As announced on 12 June 2026, the Parent Company completed an equity fundraise of gross £2.6m (the "Fundraising") being subject to shareholder approval in General Meeting to approve the issue of shares. This approval was granted on 22 June 2026.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

11

last 12 months

Capital events

3

last 24 months

Officers appointed

1

last 12 months

Officers resigned

2

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.